European Notebook: Pricing Reforms Debated In EU; Biosimilar Infliximab; AstraZeneca's HQ Build
Executive Summary
European policymakers look at options such as greater information exchange between countries to strengthen price negotiation, joint procurement, and more collaborative HTA reviews to help hold down the high prices of certain medicines; Hospira expands its biosimilar infliximab into major markets.